Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
Clinical trial NCT03884075 · RECRUITING
Trial details
- NCT number
- NCT03884075
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-24
- Primary completion
- 2027-09-03
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.